Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome

類似資料

• CAR T cell therapy becomes CHIC: “cytokine help intensified CAR” T cells
  著者:: Simone Thomas, 等
  出版事項: (2023-01-01)
• Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome
  著者:: Hanfei Guo, 等
  出版事項: (2022-03-01)
• Construction and Functional Characterization of a Fully Human Anti-mesothelin Chimeric Antigen Receptor (CAR) Expressing T Cell
  著者:: Leila Jafarzadeh, 等
  出版事項: (2020-06-01)
• Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date
  著者:: Si S, 等
  出版事項: (2020-08-01)
• Foreign or Domestic CARs: Receptor Ligands as Antigen-Binding Domains
  著者:: Donald R. Shaffer, 等
  出版事項: (2014-01-01)